Casdin Capital’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-375,000
| Closed | -$2.44M | – | 37 |
|
|
2018
Q3 | $2.44M | Hold |
375,000
| – | – | 0.3% | 34 |
|
|
2018
Q2 | $2.87M | Sell |
375,000
-260,000
| -41% | -$1.99M | 0.4% | 30 |
|
|
2018
Q1 | $14.2M | Buy |
635,000
+160,000
| +34% | +$3.58M | 2.5% | 18 |
|
|
2017
Q4 | $6.06M | Buy |
475,000
+75,175
| +19% | +$958K | 1.47% | 20 |
|
|
2017
Q3 | $6.23M | Buy |
399,825
+239,825
| +150% | +$3.74M | 1.76% | 20 |
|
|
2017
Q2 | $2.25M | Buy |
160,000
+30,000
| +23% | +$421K | 0.83% | 26 |
|
|
2017
Q1 | $2.86M | Buy |
+130,000
| New | +$2.86M | 1.69% | 23 |
|